As larger trials would soon reveal, the answer wasnt so simple The Cracks Begin to Show: Negative Phase 3 Trials For a while, it seemed like GLP-1 receptor agonists (GLP-1 RAs) were on track to become the first disease-modifying therapy for PD
The body's complex antioxidant system is influenced by dietary intake of non-enzymatic antioxidants such as manganese, copper, selenium and zinc, beta-carotenes, vitamin C, vitamin E, taurine, hypotaurine, and B vitamins [12]
Establishing care with a physician familiar with their full history before enrolling is strongly advisable for these patients
While side effects such as nausea and dizziness are more common, they are generally manageable and should be weighed against the potential metabolic improvements
"In my practice, GLP-1s are one of the tools I use for improving metabolic health, says Daniel McGee, D.O., a board-certified family medicine physician, The cardiovascular data has been encouraging, and in the right patients theyre usually well tolerated and can really help make a difference when combined with lifestyle changes." There are a few reasons why GLP-1 medications influence the cardiovascular system: Weight loss: Obesity and being overweight are risk factors for heart disease